Greenhouse Gas Emissions
Last 3 Years Emissions Data Summary
Y2021 | Y2020 | Y2019 | |
---|---|---|---|
Scope 1 | 245,882 | 240,052 | 285,798 |
Scope 2 - location-based | 207,005 | 228,727 | 239,619 |
Scope 2 - market-based | 21,135 | 32,218 | 133,971 |
Scope 1-2 - location-based | 452,887 | 468,779 | 525,417 |
Scope 1-2 - market-based | 267,017 | 272,270 | 419,769 |
Scope 3 | 6,581,749 | 5,985,733 | 7,234,606 |
Total - location-based | 7,034,636 | 6,454,512 | 7,760,023 |
Total - market-based | 6,794,993 | 6,202,638 | 7,571,537 |
Note: Data sources detailed here
Y2022 | Y2021 | |
---|---|---|
Total CO2e estimate (by Net0Tracker) | 2,566,929 | 6,794,993 |
Methodology | Pre-calculated sector intensity (revenue) | As reported |
Carbon emissions are estimated according to comparable years, intensity and sector benchmarks
Performance vs. Target
Value Chain (scope 3) Emissions by Category
Emissions Trajectory (Full Scopes)
Emissions Trajectory not available
Sector Benchmark
Note: Latest GHG and revenue data (based on tradingview.com) are used to calculate GHG emissions intensity by sector. The color scale of each bubble depends on the GHG intensity (GHG emissions per 1 million USD revenue). Sectors follow the Global Industry Classification Standard (GICS) that organize companies based on their primary business activities. The 11 sectors are : Information Technology, Health Care, Financials, Consumer Discretionary, Communication Services, Industrials, Consumer Staples, Energy, Utilities, Real Estate, and Materials.
AstraZeneca belongs to the sector Health Care.
Reduction and Net Zero Targets
>Note: intensity targets are not represented in the current version - see Methodology
Gross Absolute Emission Reductions
There is no absolute emission reduction recorded in our database. Email us to report missing information Email
Net Absolute Emission Reductions
There is no absolute emission reduction recorded in our database. Email us to report missing information Email
Net Zero Future Commitments
There is no net zero target recorded in our database. Email us to report missing information Email
Science-based Targets (SBTI)
Date Published / Updated :01/10/2021
Near-term | Long-Term | Net Zero Standard |
---|---|---|
Targets Set : 1.5°C by FY2026, FY2030 | Targets Set : 1.5°C by FY2045 | Yes by FY2045 |
Global biopharmaceutical company AstraZeneca commits to reach net-zero greenhouse gas emissions across the value chain by FY2045.
Near-Term Targets
Global biopharmaceutical company AstraZeneca commits to reduce absolute scope 1 and 2 GHG emissions 98% by FY2026 from a FY2015 base year, and to reduce absolute scope 3 GHG emissions 50% by FY2030 from a FY2019 base year. Within this target, AstraZeneca commits to reduce absolute scope 3 GHG emissions from fuel and energy related activities, upstream leased assets and downstream leased assets 80% by FY2030; from use of sold products 95% by 2030; and from upstream transportation and distribution, waste generated in operations, business travel, employee commuting and end of life treatment of sold products 46% by FY2030, all from a 2019 base year. Furthermore, AstraZeneca commits that 95% of its suppliers by spend covering purchased goods and services and capital goods, and 50% of its suppliers by spend covering upstream transportation and distribution and business travel, will have science-based targets by FY2025.
Long-Term Targets
AstraZeneca also commits to reduce absolute scope 3 GHG emissions 90% by FY2045 from a FY2019 base year.
Offsets
Last update for AstraZeneca by zerotracker.net: Sept. 4, 2024Planning to use external offset credits | Not Specified |
Separate targets for emission reductions and removals | Yes |
Conditions on use of offset credits | None |
Plans for carbon dioxide removal (CDR) | Yes (nature-based and CCS-based removals) |
Additional notes: Actor has plan ('AZ forest') to engage in reforestation as part of carbon negative target. Target of 50 million trees planted and maintained by 2025. Does not explicitely read that this will be within its target boundary, but states it 'will partner with recognised reforestation organisations and governments in a number of countries' https://www.astrazeneca.com/media-centre/press-releases/2020/astrazenecas-ambition-zero-carbon-strategy-to-eliminate-emissions-by-2025-and-be-carbon-negative-across-the-entire-value-chain-by-2030-22012020.html Actor does however have a plan to use carbon removal starting from 2026 onwards until at least 2045 to "compensate for any residual Scope 1 and 2 emission through high quality removals using bioenergy with carbon capture and storage (BECCS)". https://www.astrazeneca.com/content/dam/az/Sustainability/2023/pdf/Sustainability_Report_2022.pdf Brief mention of purchasing external carbon offsets in 2018 sustainability report, but this was not kept in the 2022 edition. https://www.astrazeneca.com/content/dam/az/Sustainability/2019/Sustainability_Report_2018.pdf
Score Summary
Ref | Principle |
Score
(points) |
Max
(points) |
Delta
(points) |
---|---|---|---|---|
1 | At least 2 years of GHG emissions for scope 1 and 2 are publicly-available and externally-verified | 0.0 | 10.0 | - |
2 | Scope 3 emissions are fully reported and externally-verified | 0.0 | 10.0 | - |
3 | CDP score demonstrates the level of transparent disclosures | 10.0 | 10.0 | - |
Transparency | 10.0 | 30.0 | - | |
4 | Net Zero Commitments by 2050 include an intermediate target and cover all the emissions | 0.0 | 10.0 | - |
5 | Net Zero targets demonstrate a high-level of emergency | 0.0 | 10.0 | - |
6 | Emission reduction targets on a forward-looking basis are ambitious | 0.0 | 10.0 | - |
7 | Targets are science-based as validated by SBTi | 10.0 | 10.0 | - |
Commitments | 10.0 | 40.0 | - | |
8 | Results re. operational emissions reduction: on-pace (performance-to-date) and momentum (forward-looking targets) | 0.0 | 10.0 | - |
9 | Results re. value chain emissions reduction: on-pace (performance-to-date) and momentum (forward-looking targets) | 0.0 | 10.0 | - |
10 | Implied Temperature Rating by MSCi | 0.0 | 10.0 | - |
Results | 0.0 | 30.0 | - | |
Total | 20.0 | 100.0 | - |
Score Details
Criteria | Results | 2023 Score | 2022 Score | Vs. 2022 | 2021 Score |
---|---|---|---|---|---|
Criteria 1 : Transparency on operational emissions (Scope 1 + 2) | |||||
Are S1+S2 figures publicly-disclosed for the last reporting year and the preceding period? | NC | 0.0 / 5.0 | - | ||
Are S1+S2 figures verified by a 3rd-party for the last reporting year? | NC | 0.0/ 5.0 | - | ||
Criteria 2 : Transparency on value chain emissions (Scope 3) | |||||
Are the 15 categories fully or partly disclosed? | NC | 0.0 / 5.0 | - | ||
Are S3 figures fully or partly verified by a 3rd-party for the last reporting year? | NC | 0.0 / 5.0 | - | ||
Criteria 3 : Quality and Frequency of reporting | |||||
What is the latest CDP score (no later than the preceding year)? | A | 10.0 / 10.0 | - | ||
How many interim reporting were provided between 2 reporting periods (GHG emissions only)? | |||||
Criteria 4 : Net Zero Commitments | |||||
Does the net 0 target include a statement of a generally-accepted net zero emission target by 2050? | NC | 0.0 / 3.0 | - | ||
Does the net zero target include an intermediate target by 2030? | NC | 0.0 / 3.0 | - | ||
Does the net zero target include all the emissions? | NC | 0.0 / 4.0 | - | ||
Criteria 5 : Target year for Net Zero Commitments | |||||
Target year for achieving net zero emissions for S1+S2? | NC | 0.0 / 5.0 | - | ||
Target year for achieving net zero emissions for S1+S2+S3 combined? | NC | 0.0 / 5.0 | - | ||
Criteria 6 : Reduction objectives | |||||
What is the forward-looking GHG% reduction (without compensation) for scope 1+2? | 0.0 / 5.0 | - | |||
What is the forward-looking GHG% reduction (without compensation) for scope 1+2+3? |
No target found
|
0.0 / 5.0 | - | ||
Criteria 7 : Science-Based Targets | |||||
What type of science-based target (as validated by SBTi) did the company commit to? | Targets Set 1.5°C | 10.0 / 10.0 | - | ||
Criteria 8 : Results based on scope 1 - 2 | |||||
Performance to date: cumulative% reduction vs. target |
Objective (in %):
Actual (in %): No target found
|
0.0 / 5.0 | - | ||
Momentum: last year % reduction vs. forward-looking target |
Objective (in %):
Actual (in %): No target found
|
0.0 / 5.0 | - | ||
Criteria 9 : Results based on scope 1 - 2 - 3 | |||||
Performance to date: cumulative% reduction vs. target |
Objective (in %):
Actual (in %): No target found
|
0.0 / 5.0 | - | ||
Momentum: last year % reduction vs. forward-looking target |
Objective (in %):
Actual (in %): No target found
|
0.0 / 5.0 | - | ||
Criteria 10 : Implied Temperature Rise (ITR) | |||||
Is the company aligned with global climate targets? | ITR: None°C | 0.0 / 10.0 | - | ||
Total | 20.0 / 100.0 | - |
Available Data Sources
Reporting Year | 2021 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Source | NZPDU | Yourstake | NZPDU | NZPDU | NZPDU |
Publication Year | 2022 | unknown | 2021 | 2020 | 2019 |
Scope 1 | 245,882 | 245,882 | 240,052 | 285,798 | 301,896 |
Scope 2 - location-based | 207,005 | 207,005 | 228,727 | 239,619 | 253,987 |
Scope 2 - market-based | 21,135 | 21,135 | 32,218 | 133,971 | 144,863 |
Scope 1-2 - location-based | 452,887 | 452,887 | 468,779 | 525,417 | 555,883 |
Scope 1-2 - market-based | 267,017 | 267,017 | 272,270 | 419,769 | 446,759 |
Scope 3 | 6,581,749 | 6,581,749 | 5,985,733 | 7,234,606 | 6,264,535 |
Total - location-based | 7,034,636 | 7,034,636 | 6,454,512 | 7,760,023 | 6,820,418 |
Total - market-based | 6,794,993 | 6,848,766 | 6,202,638 | 7,571,537 | 6,647,686 |
Sources
- Yourstake: Data from YourStake.org - see Free SFDR data library
© Vincent Manier - September 2021 About us . Keep in touch . Blog